Newly passed House bill could close orphan drug loophole ...
文章推薦指數: 80 %
The FDA can grant seven years of market exclusivity to a drug if it's intended to treat a condition affecting fewer than 200,000 patients in the U.S., ... Skiptomaincontent Pharma NewlypassedHousebillcouldcloseorphan
延伸文章資訊
- 1Orphan Drugs in the United States - IQVIA
- 2Market exclusivity: orphan medicines | European Medicines ...
Expiry of market exclusivity ... When the period of market exclusivity for an indication ends, th...
- 3ORPHAN DRUGS IN THE UNITED STATES: - National ...
development in the rare disease space by offering grants, tax credits for clinical trial costs, w...
- 4Newly passed House bill could close orphan drug loophole ...
The FDA can grant seven years of market exclusivity to a drug if it's intended to treat a conditi...
- 5Court ruling in orphan drug lawsuit reframes outlook on ...
Under orphan-drug exclusivity, the FDA may not approve another sponsor's application for the same...